Riskpilot← Back to searchSign inGet full accessDermaCut AB
ABActiveOrg 5591593867Norr Mälarstrand 60 6trManufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 20181-4 employees
Revenue 2025
SEK 1,7M
+15% vs 2024
EBITDA margin
1.3%
-40% vs 2024
Equity ratio
6.6%
Financial strength
Net profit 2025
SEK 2K
| Revenue | SEK 1,7M | +15% |
| EBITDA | SEK 23K | -40% |
| Net profit | SEK 2K | — |
| Total assets | SEK 936K | +19% |
| Equity | SEK 62K | +3% |
| Employees | — | — |
Legal name
DermaCut AB
Org number
5591593867
Legal form
Aktiebolag
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
18 maj 2018
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolaget ska tillverka operationsknivar, driva utvecklingsverksamhet som rör transplantation av vävnader ffa hud, brännskador, sårläkning och behandling av svårläkta sår samt därmed förenlig verksamhet
Address
Norr Mälarstrand 60 6tr
Email
sjoberg.folke@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 124 | 641 | 967 | 1 509 | 1 735 |
| Staff expenses | — | — | — | — | −810 |
| EBITDA | 12 | 52 | 41 | 38 | 23 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 12 | 52 | 41 | 38 | 23 |
| Net financials | −16 | −22 | −28 | −31 | −15 |
| Profit before tax | −4 | 31 | 14 | 7 | 8 |
| Tax | −0 | −10 | −9 | −7 | −6 |
| Net profit | −4 | 21 | 5 | 0 | 2 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 490 | 776 | 758 | 786 | 936 |
| Equity | 34 | 56 | 60 | 60 | 62 |
| Long-term debt | 272 | 256 | 275 | 239 | 68 |
| Short-term debt | 183 | 464 | 423 | 488 | 806 |
| Total debt | 455 | 720 | 698 | 727 | 874 |
EBITDA margin
1.3%
This company
15.8%
Market median
-92% vs market
20212025
Equity ratio
6.6%
This company
38.2%
Market median
-83% vs market
20212025
Return on equity
3.3%
This company
18.4%
Market median
-82% vs market
20212025
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20212025
Asset turnover
1.85×
This company
1.12×
Market median
+65% vs market
20212025
Debt / equity
14.14×
This company
0.62×
Market median
-2181% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BF Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Deputy Board Member | 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DermaCut AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bror Folke Sjöberg | Deputy Chief Executive Officer | 0 companies |
| Zacharias Nils Folke Sjöberg Bixo | Chairman | 0 companies |
| Karl Martin Lindborg | Deputy Board Member | 0 companies |